在阿尔茨海默氏病模型中,MAP 1A的酸化调节了Tau的高酸化
Biao Cai1,2, Nan Shao2, Ting Ye2
1State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Material Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
Neuropathology and applied neurobiology
|September 14, 2023
概括
微管相关蛋白1A (MAP 1A) 通过降低Tau酸化来保护阿尔茨海默病 (AD) 中的神经元. 低水平的酸化MAP 1A与AD中增加的Tau酸化和神经元损伤相关.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 高酸化是阿尔茨海默病 (AD) 的一个关键病理标志.
- 了解驱动Tau过酸化的机制对于阐明AD病原和神经损伤至关重要.
研究的目的:
- 调查微管相关蛋白1A (MAP 1A) 在陶化中的作用及其对阿尔茨海默病的影响.
- 探索MAP 1A影响陶酸化和神经元生存的分子机制.
主要方法:
- 建立AD的老鼠模型.
- 定量光蛋白质组学和蛋白质组学,以识别差异化蛋白质.
- 西部斑点分析以确认MAP 1A.的变化.
- 在AD细胞模型中对MAP 1A和共免疫沉试验进行siRNA介导的淘汰.
主要成果:
- 在AD模型中,MAP 1A的酸化 (p-MAP 1A) 被降低.
- 循环素依赖性激酶5 (CDK5) 对MAP 1A的结合减少,对Tau的结合增加.
- MAP 1A沉默加剧了CDK5-Tau结合和Tau酸化 (p-Tau),导致细胞存活率降低.
结论:
- 在AD中,p-MAP 1A的下调和p-Tau的上调与改变与CDK5.5的结合亲和关系有关.
- MAP 1A具有竞争性地与CDK5结合,对抗tau酸化并促进神经元的保护.
- 这些发现提供了对阿尔茨海默病变的发现和针对MAP 1A.潜在的治疗策略的见解.
相关概念视频
Phosphorylation
50.5K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.5K
Microtubule Associated Proteins (MAPs)
4.4K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.4K
Protein Kinases and Phosphatases
13.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
Calmodulin-dependent Signaling
5.2K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.2K
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


